(Q36827831)

16 August 2017

1 reference

title

Therapy insight: management of Graves' disease during pregnancy (English)

1 reference

16 August 2017

1 reference

Grace W Chan

1

1 reference

PubMed ID

17515891

16 August 2017

Susan J Mandel

series ordinal

2

1 reference

16 August 2017

1 June 2007

1 reference

Nature Clinical Practice Endocrinology and Metabolism

16 August 2017

1 reference

16 August 2017

3

1 reference

16 August 2017

6

1 reference

16 August 2017

470-478

1 reference

Subclinical hyperthyroidism and pregnancy outcomes

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Thyrotoxicosis complicating pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Subclinical hypothyroidism and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

Hyperthyroidism in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Fetal loss associated with excess thyroid hormone exposure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Maternal hyperthyroidism and congenital malformation in the offspring

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

The management of thyrotoxicosis in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Reference intervals for thyroid hormones in pregnant Chinese women

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Transient hyperthyroidism of hyperemesis gravidarum

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Pregnancy-Associated Changes in the Thyroid-Stimulating Antibody of Graves’ Disease and the Relationship to Neonatal Hyperthyroidism*

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

The Placental Transfer of Propylthiouracil, Methimazole and Carbimazole

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Antenatal carbimazole and choanal atresia: a new embryopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Adverse effects of prenatal methimazole exposure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Methimazole, carbimazole, and congenital skin defects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Impact of specific medical interventions on reducing the prevalence of mental retardation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Household food insecurity and overweight status in young school children: results from the Early Childhood Longitudinal Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Surgery during pregnancy and fetal outcome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Fetal thyroid function: diagnosis and management of fetal thyroid disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Sodium/Iodide Symporter (NIS) Gene Expression Is the Limiting Step for the Onset of Thyroid Function in the Human Fetus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Fetal and neonatal hyperthyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Sodium iodide symporter (NIS) gene expression in human placenta

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Maternal thyroid hormones early in pregnancy and fetal brain development

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Fetal and neonatal thyroid function in relation to maternal Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Thyroid disorders during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Hyperthyroidism During Pregnancy Treated with Propylthiouracil:The Significance of Maternal and Foetal Parameters

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Successful in utero treatment of fetal goiter and hypothyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Umbilical blood sampling in women with thyroid disease in pregnancy: Is it necessary?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0508

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0508

1 reference

16 August 2017

1 reference

PubMed ID

17515891